BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12800155)

  • 1. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
    Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B-cell non-Hodgkin's lymphoma.
    Nagai H; Kinoshita T; Suzuki H; Hatano S; Murate T; Saito H
    Genes Chromosomes Cancer; 1999 Jul; 25(3):277-83. PubMed ID: 10379874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An integrated physical and gene map of the 3.5-Mb chromosome 3p21.3 (AP20) region implicated in major human epithelial malignancies.
    Protopopov A; Kashuba V; Zabarovska VI; Muravenko OV; Lerman MI; Klein G; Zabarovsky ER
    Cancer Res; 2003 Jan; 63(2):404-12. PubMed ID: 12543795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fluorescence in situ hybridization map of 6q deletions in acute lymphocytic leukemia: identification and analysis of a candidate tumor suppressor gene.
    Sinclair PB; Sorour A; Martineau M; Harrison CJ; Mitchell WA; O'Neill E; Foroni L
    Cancer Res; 2004 Jun; 64(12):4089-98. PubMed ID: 15205317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer.
    Liu Y; Emilion G; Mungall AJ; Dunham I; Beck S; Le Meuth-Metzinger VG; Shelling AN; Charnock FM; Ganesan TS
    Oncogene; 2002 Jan; 21(3):387-99. PubMed ID: 11821951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homozygous deletions within the 11q13 cervical cancer tumor-suppressor locus in radiation-induced, neoplastically transformed human hybrid cells.
    Mendonca MS; Farrington DL; Mayhugh BM; Qin Y; Temples T; Comerford K; Chakrabarti R; Zainabadi K; Redpath JL; Stanbridge EJ; Srivatsan ES
    Genes Chromosomes Cancer; 2004 Apr; 39(4):277-87. PubMed ID: 14978789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Definition of a commonly deleted region in ovarian cancers to a 300-kb segment of chromosome 6q27.
    Saito S; Sirahama S; Matsushima M; Suzuki M; Sagae S; Kudo R; Saito J; Noda K; Nakamura Y
    Cancer Res; 1996 Dec; 56(24):5586-9. PubMed ID: 8971159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21.
    Henderson LJ; Okamoto I; Lestou VS; Ludkovski O; Robichaud M; Chhanabhai M; Gascoyne RD; Klasa RJ; Connors JM; Marra MA; Horsman DE; Lam WL
    Genes Chromosomes Cancer; 2004 May; 40(1):60-5. PubMed ID: 15034870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
    Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
    Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate liver tumor suppressor genes from human 11p11.2 by transcription mapping of microcell hybrid cell lines.
    Jahn JE; Ricketts SL; Coleman WB
    Int J Oncol; 2003 Jun; 22(6):1303-10. PubMed ID: 12738998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular analyses of the candidate tumor suppressor gene, PLAGL1, in benign and malignant salivary gland tumors.
    Enlund F; Persson F; Stenman G
    Eur J Oral Sci; 2004 Dec; 112(6):545-7. PubMed ID: 15560839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence in situ hybridization deletion mapping at 4p16.3 in bladder cancer cell lines refines the localisation of the critical interval to 30 kb.
    Bell SM; Zuo J; Myers RM; Knowles MA
    Genes Chromosomes Cancer; 1996 Oct; 17(2):108-17. PubMed ID: 8913728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 700-kb physical and transcription map of the cervical cancer tumor suppressor gene locus on chromosome 11q13.
    Zainabadi K; Benyamini P; Chakrabarti R; Veena MS; Chandrasekharappa SC; Gatti RA; Srivatsan ES
    Genomics; 2005 Jun; 85(6):704-14. PubMed ID: 15885497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Delineation of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization].
    Zhang Y; Zhou J; Weng L; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):20-3. PubMed ID: 10653903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expressed sequences as candidates for a novel tumor suppressor gene at band 13q14 in B-cell chronic lymphocytic leukemia and mantle cell lymphoma.
    Stilgenbauer S; Nickolenko J; Wilhelm J; Wolf S; Weitz S; Döhner K; Boehm T; Döhner H; Lichter P
    Oncogene; 1998 Apr; 16(14):1891-7. PubMed ID: 9583687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RPS6KA2, a putative tumour suppressor gene at 6q27 in sporadic epithelial ovarian cancer.
    Bignone PA; Lee KY; Liu Y; Emilion G; Finch J; Soosay AE; Charnock FM; Beck S; Dunham I; Mungall AJ; Ganesan TS
    Oncogene; 2007 Feb; 26(5):683-700. PubMed ID: 16878154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of CCND3 and BYSL as candidate targets for the 6p21 amplification in diffuse large B-cell lymphoma.
    Kasugai Y; Tagawa H; Kameoka Y; Morishima Y; Nakamura S; Seto M
    Clin Cancer Res; 2005 Dec; 11(23):8265-72. PubMed ID: 16322284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
    Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
    Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.